日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Suppressing Hepatic UGT1A1 Increases Plasma Bilirubin, Lowers Plasma Urobilin, Reorganizes Kinase Signaling Pathways and Lipid Species and Improves Fatty Liver Disease

抑制肝脏UGT1A1可增加血浆胆红素、降低血浆尿胆素、重组激酶信号通路和脂质种类并改善脂肪肝疾病

Evelyn A Bates, Zachary A Kipp, Genesee J Martinez, Olufunto O Badmus, Mangala M Soundarapandian, Donald Foster, Mei Xu, Justin F Creeden, Jennifer R Greer, Andrew J Morris, David E Stec, Terry D Hinds Jr

Evaluation of exogenous siRNA addition as a metabolic engineering tool for modifying biopharmaceuticals

评估添加外源 siRNA 作为修饰生物制药的代谢工程工具

Seshu Tummala, Michael Titus, Lee Wilson, Chunhua Wang, Carlo Ciatto, Greg Thill, Donald Foster, Chen Li, Zoltan Szabo, Andras Guttman, Brian Bettencourt, Muthuswamy Jayaraman, Jack Deroot, David Kocisko, Stuart Pollard, Klaus Charisse, Satya Kuchimanchi, Greg Hinkle, Stuart Milstein, Rachel Meyers,